Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Retained Earnings (2022 - 2026)

Rallybio's Retained Earnings history spans 4 years, with the latest figure at -$302.0 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 444217.65% to -$302.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$302.0 million, a 444217.65% decrease, with the full-year FY2025 number at -$302.0 million, down 444217.65% from a year prior.
  • Retained Earnings hit -$302.0 million in Q4 2025 for Rallybio, down from $24000.0 in the prior quarter.
  • Over the last five years, Retained Earnings for RLYB hit a ceiling of $169000.0 in Q3 2024 and a floor of -$312.2 million in Q2 2025.
  • Historically, Retained Earnings has averaged -$109.4 million across 4 years, with a median of -$272000.0 in 2023.
  • Biggest five-year swings in Retained Earnings: soared 353.33% in 2024 and later crashed 444217.65% in 2025.
  • Tracing RLYB's Retained Earnings over 4 years: stood at -$160.7 million in 2022, then skyrocketed by 100.01% to $15000.0 in 2023, then soared by 353.33% to $68000.0 in 2024, then crashed by 444217.65% to -$302.0 million in 2025.
  • Business Quant data shows Retained Earnings for RLYB at -$302.0 million in Q4 2025, $24000.0 in Q3 2025, and -$312.2 million in Q2 2025.